World Haemophilia Day - A Message from Paul Perrault (CSL Behring)
On the occassion of World Haemophilia Day, read a message from Paul Perreault, CEO of CSL Behring.
To our friends in the haemophilia and wider bleeding disorders community:
CSL Behring stands ready, together with a large variety of stakeholders around the world, to support World Hemophilia Day 2020 this April. For over 30 years, we have reiterated our commitment repeatedly to raising awareness about bleeding disorders on this day, which is so important for people in this community, particularly during the ongoing period of crisis.
As the Covid-19 virus situation evolves, we know that the needs of our patients remain the same, and we are committed to our promise of making and delivering life-saving medicines to those who depend on them. We understand that managing a chronic illness during this time can be stressful and you likely have concerns about the safety and availability of your medicines.
I personally want to assure you that our CSL Behring business, including our manufacturing and plasma collection centers, is operating. Despite the current environment, we continue to deliver an uninterrupted supply of our treatments and, as always, are committed to the highest standards of safety and quality for our products, donors and employees.
This global pandemic is a humanitarian crisis that impacts us all. As a leading biotherapeutics company, we understand the responsibilities we have, to deliver innovative solutions for high unmet medical needs.
On behalf of everyone at CSL Behring, on World Hemophilia Day 2020, my thoughts are with you and your family, friends, and communities as you manage through these uncertain times, but I am very optimistic about the work we are doing to develop a reliable, scalable and sustainable treatment solution for this devastating pandemic.
Thank you for your trust in CSL Behring. Be safe and be well.
Paul Perreault, CEO and Managing Director, CSL Limited